Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

guadecitabine MeSH Supplementary Concept Data 2025


MeSH Supplementary
guadecitabine
Unique ID
C580831
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C580831
Entry Term(s)
SGI-110
Pharm Action
Antineoplastic Agents
Registry Numbers
2KT4YN1DP7
0
CAS Type 1 Name
guanosine, 2'-deoxy-5-azacytidylyl-(3'-5')-2'-deoxy-
Heading Mapped to
Azacitidine / analogs & derivatives
Frequency
61
Note
a 5-aza-2'-deoxycytidine-containing demethylating dinucleotide used in the treatment of acute myeloid leukemia
Source
Cancer Immunol Immunother. 2013 Mar;62(3) 605-14
Indexing Information
Immunologic Factors
Date of Entry
2013/05/01
Revision Date
2016/11/16
guadecitabine Preferred
SGI-110 Narrower
page delivered in 0.004s